FDA Medical Device Classification Guide: Classes I, II, III, Registration, and Audit Requirements (2026)
If you are preparing to bring a medical device into the United States, FDA medical device classification is the first decision that shapes everything else: how much clinical data you need, how long approval takes, and what registration and audit obligations follow once you are on the market.
Getting the classification wrong, or treating it as a one-time step instead of the start of an ongoing compliance relationship, is one of the most common and costly mistakes we see manufacturers make. This guide covers the three FDA device classes, how to register and list a device once you know your class, and how often the FDA checks in after you start selling.
The three classes explained in 3 minutes · G.O.L Solution
Chapters
- 0:22The three FDA device classes and what separates them
- 0:46Class I — lowest risk, fastest route to market
- 1:12Class II — moderate risk and the 510(k) pathway
- 1:40Class III — highest risk and premarket approval
- 2:02How to classify your own device
What Is FDA Medical Device Classification?
The FDA defines a medical device broadly: any product designed, manufactured, or used for diagnosis, prevention, treatment, or alleviation of disease, as well as products that regulate body structure or function — from a tongue depressor to an implanted pacemaker.
The FDA sorts every device into one of three classes based on the risk it poses to the patient, and organizes those devices across 16 medical specialties covering more than 1,700 distinct device types. Class I devices make up about 47% of approved devices on the market. Class III, the highest risk tier, makes up roughly 10%.
Class I: Low-Risk Devices
Class I covers devices not intended to support or sustain life, with minimal patient contact that avoids internal organs, the central nervous system, and the cardiovascular system. Examples include electric toothbrushes, tongue depressors, oxygen masks, bandages, and non-electric wheelchairs.
Most Class I devices are exempt from premarket notification and only need to meet the FDA’s General Controls: registration, correct labeling, and a working quality management system. This makes Class I the fastest path to market of the three.
Class II: Moderate-Risk Devices
Class II devices carry more risk than Class I, often with continuous or internal patient contact. Catheters, blood pressure cuffs, pregnancy test kits, syringes, and contact lenses all fall into this class.
Most Class II devices require a 510(k) premarket notification, which means demonstrating that your device is substantially equivalent to a device already legally on the market. Class II also brings Special Controls on top of General Controls — things like specific labeling requirements, performance standards, and post-market surveillance.
Class III: High-Risk Devices
Class III is reserved for devices that sustain or support life, that are implanted, or that carry a potential unreasonable risk of illness or injury. Pacemakers, defibrillators, breast implants, and cochlear implants are typical examples.
Class III devices almost always require Premarket Approval (PMA), the FDA’s most rigorous pathway. PMA calls for clinical trial data, extensive quality system review, and a documented risk-benefit analysis. A 510(k) is possible for Class III only if a predicate device existed before 1976, which is increasingly rare.
At a glance:
| Device Class | Premarket Process | FDA Review Type | Post-Market Surveillance |
|---|---|---|---|
| Class I | Often exempt from 510(k) | General Controls only | Minimal |
| Class II | Requires 510(k) clearance | General + Special Controls | Moderate |
| Class III | Requires PMA | General + Special + PMA review | Extensive |
GOL Insight
During Covid, we helped more than 50 medical device businesses bring devices into the US market under Emergency Use Authorization (EUA) — a temporary pathway the FDA used to speed up access to devices like test kits, ventilators, and PPE during the public health emergency.
When each EUA expired, we transitioned those clients from emergency authorization to standard classification and registration, which is a different process from starting a device’s FDA journey from scratch. If your device entered the US under an EUA, your registration path from here is not the same as a brand-new Class I, II, or III submission. See how we handle FDA medical device registration.
How to Register Your Device with the FDA
Classification tells the FDA how much scrutiny your device needs. Registration and listing are how the FDA actually knows your device, and your company, exist.
Establishment Registration and Device Listing
Every facility involved in manufacturing, importing, reprocessing, or distributing a medical device for the US market has to register with the FDA, whether the facility is domestic or overseas. Registration and listing are handled entirely electronically through the FDA Unified Registration and Listing System (FURLS). You will still see them referred to by their legacy form numbers — Form FDA 2891 for establishment registration, Form FDA 2892 for device listing — but there is no paper submission.
Registration has to happen before you distribute a device in the US, and it renews annually between October 1 and December 31. Missing a renewal, or failing to update your listing within 30 days of a manufacturing or design change, can lead to fines or enforcement action.
Choosing Your Premarket Pathway
Most Class II devices go through 510(k), where you show your device is substantially equivalent to a predicate device already on the market in terms of intended use, technology, and performance. Class III devices generally need PMA, which requires clinical data and a full FDA scientific review.
There is a third option that gets overlooked: De Novo classification. If your device is genuinely novel and does not have a predicate to compare against, but the FDA agrees it carries low to moderate risk, De Novo lets the agency create a new classification for it instead of defaulting to the Class III, PMA route. This can be a faster path for innovative devices than manufacturers expect.
Quality System Requirements and Labeling
Once registered, your facility has to operate a compliant quality management system under 21 CFR Part 820. Note that this changed recently. Since 2 February 2026, Part 820 is the Quality Management System Regulation (QMSR), which amended the former Quality System Regulation and incorporates ISO 13485:2016 by reference. If you are working from guidance written before 2026, it will describe the older QSR framework.
The substance still covers design controls, document control, production and process records, and complaint handling — but those requirements are now framed against the ISO standard rather than the FDA’s older standalone text. Manufacturers already certified to ISO 13485 are in a considerably better starting position than they were.
Devices also need a Unique Device Identifier (UDI), submitted to the FDA’s Global Unique Device Identification Database (GUDID), which supports recalls and adverse event tracking.
Labeling requirements under 21 CFR Part 801 cover the device name, intended use, manufacturer information, warnings, and instructions for use. If your device serves patients who speak multiple languages, plan your labeling review for that early rather than as an afterthought.
How Often Does the FDA Audit Medical Device Manufacturers?
FDA inspections are not a one-time event tied to your original approval. The FDA runs several types of inspections: Pre-Approval Inspections when you submit a new device application, Routine Inspections on a set schedule, Compliance Follow-Up Inspections after a previous significant finding, and For Cause Inspections triggered by a specific reported issue. Some inspections are unannounced.
There is no fixed interval you can plan around. Inspection frequency is risk-based, and depends on your device class, your compliance history, and the FDA’s current priorities — higher-risk and implantable devices attract more attention than low-risk ones. Since 2 February 2026 the FDA has inspected under an updated compliance program aligned to the QMSR, replacing the Quality System Inspection Technique (QSIT) used previously.
Beyond FDA inspections, your quality management system requires you to run your own internal audits — that obligation sits with you regardless of when the FDA next visits.
If you sell into multiple countries, the Medical Device Single Audit Program (MDSAP) is worth knowing about. A single MDSAP audit can satisfy device regulators in the US, Canada, Australia, Brazil, and Japan at once, instead of preparing for five separate national audits.
When This Guide Does Not Apply
This overview covers the standard classification and registration path for physical medical devices. A few situations follow different rules. Software as a Medical Device (SaMD) and combination products that pair a device with a drug or biologic often follow modified classification logic that goes beyond what is covered here.
Devices that entered the US market under an Emergency Use Authorization follow a distinct transition process once that EUA ends, not a fresh Class I, II, or III submission from zero. And this guide is educational, not a substitute for a formal classification determination from the FDA or a regulatory consultant working from your device’s specific intended use and technology.
Frequently Asked Questions
What is the difference between FDA Class I, II, and III medical devices?
The difference comes down to risk and patient contact. Class I devices carry the lowest risk and are mostly exempt from premarket review. Class II devices need a 510(k) showing substantial equivalence to an existing device. Class III devices, which are usually implanted or life-sustaining, need full Premarket Approval with clinical data.
How do I register and list a medical device with the FDA?
You register your establishment with Form FDA 2891 and list your device with Form FDA 2892, both filed through FURLS. Depending on your class, you will also need a 510(k), a PMA, or a De Novo submission before you can legally market the device, and your listing has to be renewed every year between October 1 and December 31.
How often will the FDA audit my facility?
There is no fixed interval. Inspection frequency is risk-based and depends on your device class, your compliance history, and the FDA’s current priorities, with higher-risk and implantable devices attracting more attention. If you sell into other markets too, an MDSAP audit can cover the US alongside Canada, Australia, Brazil, and Japan in a single visit.
Does a medical device manufacturer based in Southeast Asia need a US agent to register with the FDA?
Yes. Any foreign establishment manufacturing devices for the US market has to designate a US Agent as its point of contact with the FDA. We handle this directly for clients registering from Singapore, Malaysia, Vietnam, and elsewhere in the region.
My device was authorized under an EUA. Do I need to start the registration process over?
No, but you do need a transition plan. Moving from EUA to standard classification and registration is a different process from a first-time submission, and the timeline depends on how your specific EUA is being phased out. This is exactly the situation we have guided more than 50 device manufacturers through since the pandemic.
Ready to Register Your Medical Device with the FDA?
GOL Solution has guided more than 50 medical device manufacturers through FDA classification, registration, and the transition off Emergency Use Authorization. If you are preparing to bring a device into the US market, or you need to move a device off an expiring EUA, talk to our team about the classification and registration path that fits your product.
Talk to an Expert See our FDA Medical Device Registration servicesRead the full video transcript
Are you a medical device manufacturer looking to enter the US market? The FDA classification system can make or break your success. In the next few minutes I’ll walk you through the three FDA medical device classes and how each affects your path to market approval. I’m from G.O.L Solution — let’s demystify this critical process.
The FDA classifies medical devices into three classes based on risk to patients. This determines your regulatory requirements, approval timeline and costs. Class I devices make up 47% of FDA-regulated devices — lowest risk, fastest approval. Class II represents 43% — moderate risk, moderate requirements. Class III is just 10% — highest risk, most rigorous review.
Class I devices pose minimal risk: bandages, tongue depressors, electric toothbrushes, hospital beds. They have minimal patient contact and don’t interact with critical body systems. The advantage is that most Class I devices are exempt from 510(k) requirements and subject only to general controls — device registration, proper labelling, and good manufacturing practices. This means faster, cheaper market entry.
Class II devices have sustained patient contact and moderate risk: catheters, blood pressure cuffs, continuous glucose monitors, ventilators. These require 510(k) premarket notification proving your device is substantially equivalent to an existing approved device. You’ll need comprehensive testing data and compliance with special controls. Timeline: several months, and moderate investment, but manageable for most manufacturers.
Class III devices are life-sustaining or implanted: pacemakers, artificial hearts, defibrillators. Only 10% of devices, but they undergo the most rigorous review. These require premarket approval, or PMA — clinical trials, comprehensive safety data, quality system review. We’re talking two to five years and millions in investment.
To classify your device, navigate FDA regulations. Find your device category among 16 medical specialties. Locate your device equivalent and code. Critical point: if no equivalent exists in the FDA database, you’re likely facing Class III classification by default. Innovation comes with regulatory complexity.
Understanding classification is just the beginning. At G.O.L Solution we guide medical device manufacturers through every step — from classification consultation to 510(k) applications to PMA support. Our services include facility registration, device listing, US agent representation, and label consultation. We’ve helped hundreds of companies successfully enter the US market, especially at the height of the COVID-19 pandemic.
Ready to enter the US medical device market? Contact G.O.L Solution for a consultation.
